9-Hydroxy-6,7-dimethoxydalbergiquinol inhibits osteoclast differentiation through down-regulation of Akt, c-Fos and NFATc1.
@article{Kim20149Hydroxy67dimethoxydalbergiquinolIO, title={9-Hydroxy-6,7-dimethoxydalbergiquinol inhibits osteoclast differentiation through down-regulation of Akt, c-Fos and NFATc1.}, author={J. Kim and Yoon-Hee Cheon and S. C. Kwak and J. Baek and Y. Kim and K. Yoon and Jaemin Oh and M. S. Lee}, journal={International immunopharmacology}, year={2014}, volume={20 1}, pages={ 213-20 } }
Recently, natural plant-derived products have been recognized as one of the main sources for drug discovery and development in human disease. 9-Hydroxy-6,7-dimethoxydalbergiquinol (HDDQ) isolated from the heart wood of Dalbergia odorifera is widely used in oriental medicine, however, the pharmacological effect of HDDQ in osteoclast-associated diseases remains unknown. In this study, HDDQ dose-dependently inhibited the early stage of RANKL-mediated osteoclast differentiation in bone marrow… CONTINUE READING
Topics from this paper
13 Citations
17-Hydroxy-jolkinolide A inhibits osteoclast differentiation through suppressing the activation of NF-κB and MAPKs.
- Chemistry, Medicine
- International immunopharmacology
- 2015
- 10
Formononetin attenuates osteoclastogenesis via suppressing the RANKL-induced activation of NF-κB, c-Fos, and nuclear factor of activated T-cells cytoplasmic 1 signaling pathway.
- Chemistry, Medicine
- Journal of natural products
- 2014
- 27
Calycosin Suppresses RANKL-Mediated Osteoclastogenesis through Inhibition of MAPKs and NF-κB
- Biology, Medicine
- International journal of molecular sciences
- 2015
- 27
- PDF
2,4,5-Trimethoxyldalbergiquinol promotes osteoblastic differentiation and mineralization via the BMP and Wnt/β-catenin pathway
- Biology, Medicine
- Cell Death and Disease
- 2015
- 44
- PDF
Anemonin Attenuates RANKL-Induced Osteoclastogenesis and Ameliorates LPS-Induced Inflammatory Bone Loss in Mice via Modulation of NFATc1
- Chemistry, Medicine
- Frontiers in Pharmacology
- 2019
- 3
- PDF
Harpagoside Inhibits RANKL-Induced Osteoclastogenesis via Syk-Btk-PLCγ2-Ca(2+) Signaling Pathway and Prevents Inflammation-Mediated Bone Loss.
- Biology, Medicine
- Journal of natural products
- 2015
- 20
Protocatechuic Acid Attenuates Osteoclastogenesis by Downregulating JNK/c‐Fos/NFATc1 Signaling and Prevents Inflammatory Bone Loss in Mice
- Medicine
- Phytotherapy research : PTR
- 2016
- 17
Massive elimination of multinucleated osteoclasts by eupatilin is due to dual inhibition of transcription and cytoskeletal rearrangement
- Biology, Medicine
- Bone reports
- 2015
- 9
Tatarinan O, a lignin-like compound from the roots of Acorus tatarinowii Schott inhibits osteoclast differentiation through suppressing the expression of c-Fos and NFATc1.
- Medicine
- International immunopharmacology
- 2016
- 15
Tatarinan N inhibits osteoclast differentiation through attenuating NF‐&kgr;B, MAPKs and Ca2+‐dependent signaling
- Chemistry, Medicine
- International immunopharmacology
- 2018
- 9
References
SHOWING 1-10 OF 32 REFERENCES
c-Fos protein as a target of anti-osteoclastogenic action of vitamin D, and synthesis of new analogs.
- Biology, Medicine
- The Journal of clinical investigation
- 2006
- 96
- PDF
Isoliquiritigenin, from Dalbergia odorifera, up-regulates anti-inflammatory heme oxygenase-1 expression in RAW264.7 macrophages
- Biology, Medicine
- Inflammation Research
- 2008
- 73
α-Lipoic Acid Inhibits Inflammatory Bone Resorption by Suppressing Prostaglandin E2 Synthesis1
- Chemistry, Medicine
- The Journal of Immunology
- 2006
- 81
- PDF
Nuclear Factor of Activated T-cells (NFAT) Rescues Osteoclastogenesis in Precursors Lacking c-Fos*
- Biology, Medicine
- Journal of Biological Chemistry
- 2004
- 464
- PDF
Akt Induces Osteoclast Differentiation through Regulating the GSK3β/NFATc1 Signaling Cascade
- Chemistry, Medicine
- The Journal of Immunology
- 2012
- 133
- PDF
Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families.
- Biology, Medicine
- Endocrine reviews
- 1999
- 2,098
- PDF
The phosphatidylinositol 3-kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation.
- Biology, Medicine
- Bone
- 2002
- 257
Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation
- Biology, Medicine
- Nature Genetics
- 2000
- 289
JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms
- Biology, Medicine
- Journal of Cell Science
- 2002
- 274
- PDF